In line with these findings, Ghouzlani et al. [31] reported a correlation between increased IGSF11 expression and elevated TGF-β levels in glioma patients, further suggesting its contribution to immunosuppressive signaling within the TME. The gene discussed is IGSF11; the disease is central nervous system cancer.